> top > docs > PMC:7311890 > spans > 21353-25227 > annotations

PMC:7311890 / 21353-25227 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid_Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T27 2283-2286 https://glytoucan.org/Structures/Glycans/G56516VH denotes GM3
T28 2283-2286 https://glytoucan.org/Structures/Glycans/G91237TK denotes GM3
T29 2299-2302 https://glytoucan.org/Structures/Glycans/G56516VH denotes GM3
T30 2299-2302 https://glytoucan.org/Structures/Glycans/G91237TK denotes GM3
T31 2315-2318 https://glytoucan.org/Structures/Glycans/G56516VH denotes GM3
T32 2315-2318 https://glytoucan.org/Structures/Glycans/G91237TK denotes GM3
T33 2335-2338 https://glytoucan.org/Structures/Glycans/G56516VH denotes GM3
T34 2335-2338 https://glytoucan.org/Structures/Glycans/G91237TK denotes GM3

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T141 0-6 Body_part denotes Plasma http://purl.org/sig/ont/fma/fma62970
T142 80-85 Body_part denotes Lipid http://purl.org/sig/ont/fma/fma67264
T143 99-105 Body_part denotes Lipids http://purl.org/sig/ont/fma/fma67264
T144 200-205 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T145 306-312 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T146 370-391 Body_part denotes phosphatidylinositols http://purl.org/sig/ont/fma/fma85436
T147 393-396 Body_part denotes PIs http://purl.org/sig/ont/fma/fma85436
T148 543-545 Body_part denotes A2 http://purl.org/sig/ont/fma/fma66595
T149 577-586 Body_part denotes Cytosolic http://purl.org/sig/ont/fma/fma66836
T150 601-603 Body_part denotes A2 http://purl.org/sig/ont/fma/fma66595
T151 870-873 Body_part denotes PIs http://purl.org/sig/ont/fma/fma85436
T152 950-956 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T153 957-962 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T154 1124-1136 Body_part denotes lipoproteins http://purl.org/sig/ont/fma/fma63169
T155 1162-1164 Body_part denotes PC http://purl.org/sig/ont/fma/fma85434
T156 1174-1181 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T157 1183-1185 Body_part denotes PC http://purl.org/sig/ont/fma/fma85434
T158 1208-1213 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T159 1232-1256 Body_part denotes high-density lipoprotein http://purl.org/sig/ont/fma/fma63171
T160 1258-1261 Body_part denotes HDL http://purl.org/sig/ont/fma/fma63171
T161 1300-1302 Body_part denotes A1 http://purl.org/sig/ont/fma/fma66592
T162 1308-1310 Body_part denotes A1 http://purl.org/sig/ont/fma/fma66592
T163 1343-1350 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T164 1418-1424 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T165 1425-1428 Body_part denotes HDL http://purl.org/sig/ont/fma/fma63171
T166 1463-1469 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T167 1470-1481 Body_part denotes lipoprotein http://purl.org/sig/ont/fma/fma63169
T168 1681-1683 Body_part denotes A1 http://purl.org/sig/ont/fma/fma66592
T169 2087-2092 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T170 2223-2228 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T171 2769-2780 Body_part denotes lymphocytes http://purl.org/sig/ont/fma/fma62863
T172 2796-2800 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T173 2917-2923 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T174 3072-3077 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T175 3152-3158 Body_part denotes Plasma http://purl.org/sig/ont/fma/fma62970
T176 3159-3165 Body_part denotes Lipids http://purl.org/sig/ont/fma/fma67264
T177 3283-3288 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T178 3737-3743 Body_part denotes Lipids http://purl.org/sig/ont/fma/fma67264

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T107 43-51 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T108 558-566 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T109 659-671 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T110 691-700 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T111 804-812 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T112 908-916 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T113 978-981 Disease denotes EVD http://purl.obolibrary.org/obo/MONDO_0005737
T114 1601-1609 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T115 1853-1856 Disease denotes FFA http://purl.obolibrary.org/obo/MONDO_0016776
T116 1899-1907 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T117 2117-2121 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T118 2972-2980 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T119 3194-3202 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T120 3428-3436 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T203 0-6 http://purl.obolibrary.org/obo/UBERON_0001969 denotes Plasma
T204 71-79 http://purl.obolibrary.org/obo/UBERON_0000158 denotes Membrane
T205 236-237 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T206 306-312 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T207 543-545 http://purl.obolibrary.org/obo/CLO_0001562 denotes A2
T208 546-554 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T209 601-603 http://purl.obolibrary.org/obo/CLO_0001562 denotes A2
T210 614-624 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T211 930-931 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T212 950-956 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T213 1089-1097 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T214 1304-1310 http://purl.obolibrary.org/obo/CLO_0053413 denotes apo-A1
T215 1418-1424 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T216 1463-1469 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T217 1677-1683 http://purl.obolibrary.org/obo/CLO_0053413 denotes apo-A1
T218 1857-1859 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T219 2159-2163 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T220 2291-2295 http://purl.obolibrary.org/obo/CLO_0001046 denotes 1/16
T221 2556-2565 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membranes
T222 2710-2718 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T223 2796-2805 http://purl.obolibrary.org/obo/CL_0000000 denotes cell-type
T224 2897-2898 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T225 2917-2923 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T226 3032-3033 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T227 3152-3158 http://purl.obolibrary.org/obo/UBERON_0001969 denotes Plasma

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T241 80-85 Chemical denotes Lipid http://purl.obolibrary.org/obo/CHEBI_18059
T242 200-205 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T243 313-333 Chemical denotes glycerophospholipids http://purl.obolibrary.org/obo/CHEBI_37739
T244 344-362 Chemical denotes phosphatidic acids http://purl.obolibrary.org/obo/CHEBI_16337
T245 357-362 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T246 364-367 Chemical denotes PAs http://purl.obolibrary.org/obo/CHEBI_16337
T247 370-391 Chemical denotes phosphatidylinositols http://purl.obolibrary.org/obo/CHEBI_28874
T248 393-396 Chemical denotes PIs http://purl.obolibrary.org/obo/CHEBI_53232|http://purl.obolibrary.org/obo/CHEBI_28874
T250 459-476 Chemical denotes lysophospholipids http://purl.obolibrary.org/obo/CHEBI_16961
T251 726-730 Chemical denotes PUFA http://purl.obolibrary.org/obo/CHEBI_26208|http://purl.obolibrary.org/obo/CHEBI_76567
T253 765-785 Chemical denotes glycerophospholipids http://purl.obolibrary.org/obo/CHEBI_37739
T254 870-873 Chemical denotes PIs http://purl.obolibrary.org/obo/CHEBI_53232|http://purl.obolibrary.org/obo/CHEBI_28874
T256 957-962 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T257 1042-1062 Chemical denotes glycerophospholipids http://purl.obolibrary.org/obo/CHEBI_37739
T258 1124-1136 Chemical denotes lipoproteins http://purl.obolibrary.org/obo/CHEBI_6495
T259 1162-1164 Chemical denotes PC http://purl.obolibrary.org/obo/CHEBI_16110|http://purl.obolibrary.org/obo/CHEBI_49183|http://purl.obolibrary.org/obo/CHEBI_53201|http://purl.obolibrary.org/obo/CHEBI_55395|http://purl.obolibrary.org/obo/CHEBI_57643|http://purl.obolibrary.org/obo/CHEBI_61433
T265 1174-1181 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T266 1183-1185 Chemical denotes PC http://purl.obolibrary.org/obo/CHEBI_16110|http://purl.obolibrary.org/obo/CHEBI_49183|http://purl.obolibrary.org/obo/CHEBI_53201|http://purl.obolibrary.org/obo/CHEBI_55395|http://purl.obolibrary.org/obo/CHEBI_57643|http://purl.obolibrary.org/obo/CHEBI_61433
T272 1186-1188 Chemical denotes TP http://purl.obolibrary.org/obo/CHEBI_73662
T273 1208-1213 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T274 1232-1256 Chemical denotes high-density lipoprotein http://purl.obolibrary.org/obo/CHEBI_39025
T275 1245-1256 Chemical denotes lipoprotein http://purl.obolibrary.org/obo/CHEBI_6495
T276 1258-1261 Chemical denotes HDL http://purl.obolibrary.org/obo/CHEBI_39025
T277 1285-1299 Chemical denotes apolipoprotein http://purl.obolibrary.org/obo/CHEBI_39015
T278 1343-1350 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T279 1370-1372 Chemical denotes PI http://purl.obolibrary.org/obo/CHEBI_28874|http://purl.obolibrary.org/obo/CHEBI_53806|http://purl.obolibrary.org/obo/CHEBI_61484|http://purl.obolibrary.org/obo/CHEBI_74790
T283 1425-1428 Chemical denotes HDL http://purl.obolibrary.org/obo/CHEBI_39025
T284 1470-1481 Chemical denotes lipoprotein http://purl.obolibrary.org/obo/CHEBI_6495
T285 1756-1762 Chemical denotes lipids http://purl.obolibrary.org/obo/CHEBI_18059
T286 1793-1797 Chemical denotes DAGs http://purl.obolibrary.org/obo/CHEBI_18035
T287 1829-1833 Chemical denotes FFAs http://purl.obolibrary.org/obo/CHEBI_35366
T288 1853-1856 Chemical denotes FFA http://purl.obolibrary.org/obo/CHEBI_42638
T289 1857-1861 Chemical denotes 18:2 http://purl.obolibrary.org/obo/CHEBI_24993|http://purl.obolibrary.org/obo/CHEBI_25627
T291 1926-1930 Chemical denotes TAGs http://purl.obolibrary.org/obo/CHEBI_17855
T292 1985-1987 Chemical denotes S4 http://purl.obolibrary.org/obo/CHEBI_29401
T293 2007-2011 Chemical denotes FFAs http://purl.obolibrary.org/obo/CHEBI_35366
T294 2027-2031 Chemical denotes TAGs http://purl.obolibrary.org/obo/CHEBI_17855
T295 2087-2092 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T296 2191-2210 Chemical denotes glycerophospholipid http://purl.obolibrary.org/obo/CHEBI_37739
T297 2223-2228 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T298 2239-2251 Chemical denotes sphingolipid http://purl.obolibrary.org/obo/CHEBI_26739
T299 2263-2266 Chemical denotes SMs http://purl.obolibrary.org/obo/CHEBI_17636
T300 2283-2286 Chemical denotes GM3 http://purl.obolibrary.org/obo/CHEBI_15681|http://purl.obolibrary.org/obo/CHEBI_84118
T302 2299-2302 Chemical denotes GM3 http://purl.obolibrary.org/obo/CHEBI_15681|http://purl.obolibrary.org/obo/CHEBI_84118
T304 2303-2308 Chemical denotes d18:0 http://purl.obolibrary.org/obo/CHEBI_16566
T305 2315-2318 Chemical denotes GM3 http://purl.obolibrary.org/obo/CHEBI_15681|http://purl.obolibrary.org/obo/CHEBI_84118
T307 2335-2338 Chemical denotes GM3 http://purl.obolibrary.org/obo/CHEBI_15681|http://purl.obolibrary.org/obo/CHEBI_84118
T309 2339-2344 Chemical denotes d18:0 http://purl.obolibrary.org/obo/CHEBI_16566
T310 2423-2425 Chemical denotes S4 http://purl.obolibrary.org/obo/CHEBI_29401
T311 2481-2487 Chemical denotes lipids http://purl.obolibrary.org/obo/CHEBI_18059
T312 2619-2622 Chemical denotes SMs http://purl.obolibrary.org/obo/CHEBI_17636
T313 2665-2669 Chemical denotes DAGs http://purl.obolibrary.org/obo/CHEBI_18035
T314 3072-3077 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T315 3110-3113 Chemical denotes SMs http://purl.obolibrary.org/obo/CHEBI_17636
T316 3136-3140 Chemical denotes DAGs http://purl.obolibrary.org/obo/CHEBI_18035
T317 3283-3288 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T318 3444-3450 Chemical denotes lipids http://purl.obolibrary.org/obo/CHEBI_18059
T319 3579-3588 Chemical denotes indicator http://purl.obolibrary.org/obo/CHEBI_47867
T320 3692-3698 Chemical denotes lipids http://purl.obolibrary.org/obo/CHEBI_18059
T321 3806-3812 Chemical denotes lipids http://purl.obolibrary.org/obo/CHEBI_18059
T322 3814-3834 Chemical denotes glycerophospholipids http://purl.obolibrary.org/obo/CHEBI_37739
T323 3840-3853 Chemical denotes sphingolipids http://purl.obolibrary.org/obo/CHEBI_26739
T324 3871-3873 Chemical denotes S4 http://purl.obolibrary.org/obo/CHEBI_29401

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
562 80-85 Chemical denotes Lipid MESH:D008055
563 43-51 Disease denotes COVID-19 MESH:C000657245
566 3159-3165 Chemical denotes Lipids MESH:D008055
567 3194-3202 Disease denotes COVID-19 MESH:C000657245
576 3283-3288 Chemical denotes lipid MESH:D008055
577 3444-3450 Chemical denotes lipids MESH:D008055
578 3692-3698 Chemical denotes lipids MESH:D008055
579 3737-3743 Chemical denotes Lipids MESH:D008055
580 3806-3812 Chemical denotes lipids MESH:D008055
581 3814-3834 Chemical denotes glycerophospholipids MESH:D020404
582 3840-3853 Chemical denotes sphingolipids MESH:D013107
583 3428-3436 Disease denotes COVID-19 MESH:C000657245
640 529-545 Gene denotes phospholipase A2 Gene:5319
641 606-612 Gene denotes cPLA2α Gene:5321
642 726-730 Gene denotes PUFA Gene:9933
643 1162-1181 Gene denotes PC-transfer protein Gene:58488
644 1183-1188 Gene denotes PC-TP Gene:58488
645 1285-1302 Gene denotes apolipoprotein A1 Gene:335
646 1304-1310 Gene denotes apo-A1 Gene:335
647 1677-1683 Gene denotes apo-A1 Gene:335
648 567-575 Species denotes patients Tax:9606
649 2003-2006 Gene denotes C18 Gene:27241
650 99-105 Chemical denotes Lipids MESH:D008055
651 200-205 Chemical denotes lipid MESH:D008055
652 313-333 Chemical denotes glycerophospholipids MESH:D020404
653 344-362 Chemical denotes phosphatidic acids MESH:D010712
654 364-367 Chemical denotes PAs MESH:D010712
655 370-391 Chemical denotes phosphatidylinositols MESH:D010716
656 393-396 Chemical denotes PIs MESH:D010716
657 459-476 Chemical denotes lysophospholipids MESH:D008246
658 500-504 Chemical denotes LPCs
659 765-785 Chemical denotes glycerophospholipids MESH:D020404
660 957-962 Chemical denotes lipid MESH:D008055
661 1042-1062 Chemical denotes glycerophospholipids MESH:D020404
662 1208-1213 Chemical denotes lipid MESH:D008055
663 1756-1762 Chemical denotes lipids MESH:D008055
664 1793-1797 Chemical denotes DAGs MESH:D004075
665 2087-2092 Chemical denotes lipid MESH:D008055
666 2191-2210 Chemical denotes glycerophospholipid MESH:D020404
667 2223-2228 Chemical denotes lipid MESH:D008055
668 2239-2251 Chemical denotes sphingolipid MESH:D013107
669 2263-2266 Chemical denotes SMs MESH:D013109
670 2271-2275 Chemical denotes GM3s
671 2283-2286 Chemical denotes GM3
672 2299-2302 Chemical denotes GM3
673 2315-2318 Chemical denotes GM3
674 2335-2338 Chemical denotes GM3
675 2481-2487 Chemical denotes lipids MESH:D008055
676 2619-2622 Chemical denotes SMs MESH:D013109
677 2665-2669 Chemical denotes DAGs MESH:D004075
678 2830-2834 Chemical denotes GM3s
680 3072-3077 Chemical denotes lipid MESH:D008055
681 3118-3122 Chemical denotes GM3s
682 3136-3140 Chemical denotes DAGs MESH:D004075
683 558-566 Disease denotes COVID-19 MESH:C000657245
684 649-671 Disease denotes pulmonary inflammation MESH:D011014
685 691-700 Disease denotes infection MESH:D007239
686 804-812 Disease denotes COVID-19 MESH:C000657245
687 908-916 Disease denotes COVID-19 MESH:C000657245
688 978-981 Disease denotes EVD MESH:D019142
689 1364-1368 Disease denotes HDLs MESH:C538394
690 1593-1597 Disease denotes HDLs MESH:C538394
691 1601-1609 Disease denotes COVID-19 MESH:C000657245
692 1899-1907 Disease denotes COVID-19 MESH:C000657245
693 2117-2121 Disease denotes ARDS MESH:D012128
694 2719-2727 Disease denotes rigidity MESH:D009127
695 2972-2980 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T33 529-554 http://purl.obolibrary.org/obo/GO_0032431 denotes phospholipase A2 activity
T34 659-671 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T35 1208-1220 http://purl.obolibrary.org/obo/GO_0140353 denotes lipid efflux
T36 1214-1220 http://purl.obolibrary.org/obo/GO_0140352 denotes efflux
T37 1214-1220 http://purl.obolibrary.org/obo/GO_0140115 denotes efflux
T38 1263-1272 http://purl.obolibrary.org/obo/GO_0009058 denotes formation
T39 1285-1299 http://purl.obolibrary.org/obo/GO_0005319 denotes apolipoprotein
T40 2462-2471 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T34 2719-2727 Phenotype denotes rigidity http://purl.obolibrary.org/obo/HP_0002063

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T146 0-98 Sentence denotes Plasma Lipidome Distinctly Associated with COVID-19 Resembles Exosomal Membrane Lipid Compositions
T147 99-262 Sentence denotes Lipids with overall false discovery rate (FDR) <0.05 were shortlisted and grouped according to major lipid classes for visual clarity in a forest plot (Figure 2 ).
T148 263-576 Sentence denotes We observed reductions in major classes of plasma glycerophospholipids including phosphatidic acids (PAs), phosphatidylinositols (PIs), and PCs, with accompanying increases in their corresponding lysophospholipids (i.e., LPAs, LPIs, and LPCs) that indicate enhanced phospholipase A2 activity in COVID-19 patients.
T149 577-725 Sentence denotes Cytosolic phospholipase A2α (cPLA2α) activation was reported to trigger pulmonary inflammation following pathogen infection (Bhowmick et al., 2017).
T150 726-813 Sentence denotes PUFA-PEs were the only diacyl forms of glycerophospholipids that increased in COVID-19.
T151 814-1035 Sentence denotes Changes in phospholipidome (i.e., reductions in PCs and PIs and increases in PEs) observed in COVID-19 corroborated a previous study on plasma lipid alterations in EVD fatalities compared to survivors (Kyle et al., 2019).
T152 1036-1369 Sentence denotes Among glycerophospholipids, PCs constitute the major membrane components of circulating lipoproteins (Cole et al., 2012), and PC-transfer protein (PC-TP) promotes cellular lipid efflux in nascent high-density lipoprotein (HDL) formation mediated by apolipoprotein A1 (apo-A1) (Baez et al., 2002), the major protein component of HDLs.
T153 1370-1519 Sentence denotes PI was found to exhibit selective enrichment in plasma HDL fractions and was not detected in plasma lipoprotein-free fractions (Dashti et al., 2011).
T154 1520-1740 Sentence denotes Changes in phospholipidome therefore suggested reductions in circulating HDLs as COVID-19 progresses, which was in agreement with the observed reductions in apo-A1 (p = 0.0687) as disease severity increases (Figure S1C).
T155 1741-1989 Sentence denotes As for neutral lipids, marked reductions in several DAGs, with concomitant increases in FFAs (e.g., FFA18:1 and FFA 18:2), were observed in mild and moderate COVID-19 (Figure 2), while TAGs were significantly reduced only in mild cases (Figure S4).
T156 1990-2165 Sentence denotes Increases in C18-FFAs and diminished TAGs were in agreement with previously reported circulating lipid changes associated with ARDS (Bursten et al., 1996; Maile et al., 2018).
T157 2166-2509 Sentence denotes In stark contrast to the glycerophospholipid and neutral lipid pathways, sphingolipid classes of SMs and GM3s, e.g., GM3 d18:1/16:0, GM3 d18:0/16:0, GM3 d18:1/25:0, and GM3 d18:0/25:0, displayed progressive increases with increasing severity (Figures 2 and S4), possibly reflecting the augmented secretion of these lipids into the circulation.
T158 2510-2754 Sentence denotes Of particular interest, lipidomes of exosomal membranes were previously shown to be specifically enriched in SMs (Stoorvogel et al., 2002) with diminished DAGs that cumulatively give rise to enhanced membrane rigidity (Laulagnier et al., 2004).
T159 2755-2890 Sentence denotes Exosomes from lymphocytes also exhibited cell-type-specific enrichments in GM3s (Wubbolts et al., 2003) and PSs (Brügger et al., 2006).
T160 2891-3142 Sentence denotes Thus, a gross overview of plasma lipidomic signatures distinctly associated with COVID-19, taking into account baseline cofounders, revealed a close resemblance to that of exosomal lipid compositions (i.e., enriched in SMs and GM3s with reduced DAGs).
T161 3143-3202 Sentence denotes Figure 2 Plasma Lipids Associated with Severity of COVID-19
T162 3203-3438 Sentence denotes Logistic regression model with covariates BMI, age, and sex was built with each lipid to search for significant variables that could predict disease severity of subjects (i.e., healthy control, and mild, moderate, and severe COVID-19).
T163 3439-3520 Sentence denotes Only lipids with false discovery rate (FDR) <0.05 were shortlisted and presented.
T164 3521-3671 Sentence denotes Forest plots illustrate the magnitude of odds ratios with indicator of significance of the estimate in the model; ∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05.
T165 3672-3736 Sentence denotes For non-significant lipids, the estimates were plotted as zeros.
T166 3737-3854 Sentence denotes Lipids were broadly classified according to major classes of neutral lipids, glycerophospholipids, and sphingolipids.
T167 3855-3874 Sentence denotes See also Figure S4.

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T448 0-6 UBERON:0001969 denotes Plasma
T449 43-51 SP_7 denotes COVID-19
T450 62-70 GO:0070062 denotes Exosomal
T451 80-85 CHEBI:18059;CHEBI:18059 denotes Lipid
T452 99-105 CHEBI:18059;CHEBI:18059 denotes Lipids
T453 200-205 CHEBI:18059;CHEBI:18059 denotes lipid
T454 218-224 GO:0007601 denotes visual
T455 306-312 UBERON:0001969 denotes plasma
T456 313-333 CHEBI:37739;CHEBI:37739 denotes glycerophospholipids
T457 344-362 CHEBI:16337;CHEBI:16337 denotes phosphatidic acids
T458 364-367 CHEBI:18303;CHEBI:18303 denotes PAs
T459 370-391 CHEBI:28874;CHEBI:28874 denotes phosphatidylinositols
T460 459-476 CHEBI:16247;CHEBI:16247 denotes lysophospholipids
T461 484-488 CHEBI:16412;CHEBI:16412 denotes LPAs
T462 558-566 SP_7 denotes COVID-19
T463 577-586 GO:0005829;PR:000012804 denotes Cytosolic
T464 587-603 PR:000012804 denotes phospholipase A2
T465 606-611 PR:000012804 denotes cPLA2
T466 649-658 UBERON:0002048 denotes pulmonary
T467 749-755 CHEBI:18035;CHEBI:18035 denotes diacyl
T468 765-785 CHEBI:37739;CHEBI:37739 denotes glycerophospholipids
T469 804-812 SP_7 denotes COVID-19
T470 825-840 CHEBI:16247;CHEBI:16247 denotes phospholipidome
T471 908-916 SP_7 denotes COVID-19
T472 950-956 UBERON:0001969 denotes plasma
T473 957-962 CHEBI:18059;CHEBI:18059 denotes lipid
T474 1042-1062 CHEBI:37739;CHEBI:37739 denotes glycerophospholipids
T475 1064-1067 CHEBI:18303;CHEBI:18303 denotes PCs
T476 1089-1097 GO:0016020 denotes membrane
T477 1208-1213 CHEBI:18059;CHEBI:18059 denotes lipid
T478 1285-1299 CHEBI:39015;CHEBI:39015;PR:000004140 denotes apolipoprotein
T479 1300-1302 PR:000004140 denotes A1
T480 1418-1424 UBERON:0001969 denotes plasma
T481 1463-1469 UBERON:0001969 denotes plasma
T482 1531-1546 CHEBI:16247;CHEBI:16247 denotes phospholipidome
T483 1601-1609 SP_7 denotes COVID-19
T484 1756-1762 CHEBI:18059;CHEBI:18059 denotes lipids
T485 1793-1797 CHEBI:17855;CHEBI:17855 denotes DAGs
T486 1899-1907 SP_7 denotes COVID-19
T487 1926-1930 CHEBI:17855;CHEBI:17855 denotes TAGs
T488 2027-2031 CHEBI:17855;CHEBI:17855 denotes TAGs
T489 2087-2092 CHEBI:18059;CHEBI:18059 denotes lipid
T490 2191-2210 CHEBI:37739;CHEBI:37739 denotes glycerophospholipid
T491 2223-2228 CHEBI:18059;CHEBI:18059 denotes lipid
T492 2239-2251 CHEBI:26739;CHEBI:26739 denotes sphingolipid
T493 2287-2290 PR:Q9LZI2 denotes d18
T494 2481-2487 CHEBI:18059;CHEBI:18059 denotes lipids
T495 2547-2555 GO:0070062 denotes exosomal
T496 2556-2565 GO:0016020 denotes membranes
T497 2665-2669 CHEBI:17855;CHEBI:17855 denotes DAGs
T498 2710-2718 GO:0016020 denotes membrane
T499 2755-2763 GO:0070062 denotes Exosomes
T500 2769-2780 CL:0000542 denotes lymphocytes
T501 2830-2834 PR:000015682 denotes GM3s
T502 2863-2866 CHEBI:18303;CHEBI:18303 denotes PSs
T503 2917-2923 UBERON:0001969 denotes plasma
T504 2972-2980 SP_7 denotes COVID-19
T505 3063-3071 GO:0070062 denotes exosomal
T506 3072-3077 CHEBI:18059;CHEBI:18059 denotes lipid
T507 3118-3122 PR:000015682 denotes GM3s
T508 3136-3140 CHEBI:17855;CHEBI:17855 denotes DAGs
T509 3159-3165 CHEBI:18059;CHEBI:18059 denotes Lipids
T510 3194-3211 SP_7 denotes COVID-19 Logistic
T511 3283-3288 CHEBI:18059;CHEBI:18059 denotes lipid
T512 3428-3436 SP_7 denotes COVID-19
T513 3444-3450 CHEBI:18059;CHEBI:18059 denotes lipids
T514 3692-3698 CHEBI:18059;CHEBI:18059 denotes lipids
T515 3737-3743 CHEBI:18059;CHEBI:18059 denotes Lipids
T516 3806-3812 CHEBI:18059;CHEBI:18059 denotes lipids
T517 3814-3834 CHEBI:37739;CHEBI:37739 denotes glycerophospholipids
T518 3840-3853 CHEBI:26739;CHEBI:26739 denotes sphingolipids
T37792 103-112 CHEBI:16393;CHEBI:16393;PR:000015523 denotes ds with o
T20388 113-121 PR:000015523 denotes erall fa
T84824 125-133 CL:0000576 denotes discover
T55510 142-153 CL:0000235 denotes DR) <0.05 w
T27731 219-227 UBERON:0003215;CL:0000583 denotes isual cl
T1844 228-239 CL:0000583 denotes rity in a f
T88774 249-253 UBERON:0002048 denotes (Fi
T89554 299-306 MOP:0000568 denotes ses of
T51487 315-324 CHEBI:16990;CHEBI:16990 denotes ycerophos
T18836 342-353 GO:0045333 denotes g phosphati
T43909 403-412 CHEBI:16990;CHEBI:16990 denotes PCs, with
T77168 510-518 SP_7 denotes indicat
T75518 547-555 MOP:0000568 denotes ctivity
T49583 696-702 UBERON:0001969 denotes tion (
T62355 703-705 CHEBI:34018;CHEBI:34018 denotes ho
T54562 705-712 CHEBI:43176;CHEBI:43176 denotes wmick e
T22649 740-748 SP_7 denotes the only
T76638 843-848 SP_6;NCBITaxon:9606 denotes .e.,
T39490 849-857 UBERON:0003215 denotes eduction
T54175 868-875 CL:0002212 denotes d PIs a
T59433 951-956 NCBITaxon:10239 denotes lasma
T62411 999-1004 CHEBI:18059;CHEBI:18059 denotes ed to
T83288 1019-1034 CHEBI:18303;CHEBI:18303 denotes e et al., 2019)
T13685 1045-1067 CHEBI:32957;CHEBI:32957 denotes cerophospholipids, PCs
T34627 1069-1072 CHEBI:16412;CHEBI:16412 denotes ons
T14085 1096-1119 CHEBI:60479;CHEBI:60479 denotes e components of circula
T35535 1164-1172 SP_7 denotes -transfe
T10814 1188-1193 CHEBI:18059;CHEBI:18059 denotes ) pro
T7223 1204-1217 CHEBI:61907;CHEBI:61907 denotes lar lipid eff
T70447 1218-1221 CHEBI:17855;CHEBI:17855 denotes ux
T94425 1247-1257 CHEBI:15904;CHEBI:15904 denotes poprotein
T94275 1258-1261 CHEBI:17855;CHEBI:17855 denotes HDL
T45299 1291-1294 CHEBI:42098;CHEBI:42098 denotes opr
T42467 1367-1377 CHEBI:26739;CHEBI:26739 denotes s. PI was
T32087 1523-1531 SP_7 denotes nges in
T24069 1595-1601 UBERON:0001969 denotes Ls as
T41089 1602-1610 CHEBI:25212;CHEBI:25212 denotes OVID-19
T98256 1634-1642 SP_7 denotes agreeme
T53702 1742-1747 CHEBI:18059;CHEBI:18059 denotes s for
T77932 1763-1772 CHEBI:25212;CHEBI:25212 denotes marked r
T68728 1828-1836 SP_7 denotes FFAs (e
T51108 2754-2760 UBERON:0001969 denotes Exoso
T75001 2761-2770 CHEBI:25212;CHEBI:25212 denotes es from l
T61356 2845-2848 CHEBI:17855;CHEBI:17855 denotes et 
T98620 2913-2922 CHEBI:17500;CHEBI:17500 denotes of plasm
T27882 3002-3010 SP_7 denotes baseline
T55143 3169-3178 CHEBI:25212;CHEBI:25212 denotes ociated w
T36658 3283-3293 CHEBI:25212;CHEBI:25212 denotes lipid to s
T91890 3376-3381 CHEBI:18059;CHEBI:18059 denotes e., h
T98946 3451-3456 CHEBI:18059;CHEBI:18059 denotes with
T39180 3476-3482 UBERON:0001969 denotes (FDR)
T374 3516-3522 UBERON:0001969 denotes ted. F
T375 3549-3557 SP_7 denotes magnitud
T376 3621-3627 UBERON:0001969 denotes in the
T377 3628-3636 CHEBI:25212;CHEBI:25212 denotes model; ∗
T378 3660-3668 SP_7 denotes ∗p < 0.
T379 3771-3776 CHEBI:18059;CHEBI:18059 denotes ordin
T380 3791-3800 CHEBI:25212;CHEBI:25212 denotes ses of ne
T381 3861-3869 SP_7 denotes so Figur

2_test

Id Subject Object Predicate Lexical cue
32610096-30808769-19699495 1029-1033 30808769 denotes 2019
32610096-21979151-19699496 1151-1155 21979151 denotes 2012
32610096-11751880-19699497 1326-1330 11751880 denotes 2002
32610096-22355656-19699498 1513-1517 22355656 denotes 2011
32610096-8674324-19699499 2139-2143 8674324 denotes 1996
32610096-29636049-19699500 2159-2163 29636049 denotes 2018
32610096-11967126-19699501 2643-2647 11967126 denotes 2002
32610096-14965343-19699502 2748-2752 14965343 denotes 2004
32610096-12519789-19699503 2853-2857 12519789 denotes 2003
32610096-16481622-19699504 2884-2888 16481622 denotes 2006